Tirzepatide

Tirzepatide is a novel dual-agonist developed by Eli Lilly and Co. with the purpose of harnessing the potential of two naturally occurring incretin hormones: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) Found a

Europe: 3-7 days
International: 7-21 days
110.00€
Availability: In Stock
Premium Quality
Premium Quality
Only high-quality products from the manufacturer
Fast Delivery
Fast Delivery
Fast and secure shipping

About Tirzepatide

The digestive tract releases these incretin hormones to stimulate insulin release in response to food intake [2]. Structurally, tirzepatide is composed of 39 amino acids, featuring a modified GIP sequence at the N-terminus and a C-terminus sequence derived from the GLP-1 agonist exenatide.

 

The effects of the use of Tirzepatide

Improved glycemic control

Weight loss

Nonalcoholic fatty liver disease

Improving of sleep quality

Low risk of thyroid C cell tumors  

Application and dosage of Tirzepatide

The peptide is administered  subcutaneous injection. The weekly dosage is calculated according to the attached instructions and is 2.5 mg a week

 To prepare the solution the peptide is diluted with injection water and can be stored in the refrigerator up to 10 days.

Application information is posted for the informational purposes only.

Found a lower price? Contact us and we give you a better deal!